atracurium has been researched along with Critical Illness in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Dilokpattanamongkol, P; Nosoongnoen, W; Panusitthikorn, P; Suthisisang, C; Tangsujaritvijit, V | 1 |
| Azouzi, A; Boussarsar, M; Fraj, N; Meddeb, K; Romdhani, S; Saad, HB | 1 |
| Aubrun, F; Delignette, MC; Dziadzko, M; Mazard, T; Wallet, F; Ziatkowski-Michaud, J | 1 |
| Szakmany, T; Woodhouse, T | 1 |
| Meeder, AM; Rozendaal, A; van der Steen, MS; van Zanten, AR | 1 |
| Schneider, G | 1 |
| Kruger, PS; Liu, X; Roberts, MS; Weiss, M | 1 |
| Amygdalou, A; Behrakis, PK; Mandragos, C; Moukas, M; Takis, F; Vassiliou, MP | 1 |
| Bonmarchand, G; Duflo, A; Girault, C; Hamelin, K; Richard, JC; Tamion, F | 1 |
| De Laet, I; De Waele, JJ; Hoste, E; Verholen, E | 1 |
| Boyles, C; Choonara, I; Davies, G; Haywood, T; Hinson, G; Jenkins, I; Mayer, A; Morton, N; Playfor, S; Ralph, T; Wolf, A | 1 |
| Bowton, DL; Cardenas, VJ; Casale, EJ; Coursin, DB; Ford, SR; Howard, D; Murray, MJ; Prielipp, RC; Scuderi, PE; Vender, J | 1 |
| Coursin, DB; Meyer, DA; Prielipp, RC | 1 |
| Hunter, JM | 1 |
| Hoey, LL; Tschida, SJ; Vance-Bryan, K | 1 |
| Boyd, AH; Eastwood, NB; Hunter, JM; Parker, CJ | 1 |
| Tobias, JD | 1 |
| Beale, RJ; Bion, JF; Boyd, AH; Eastwood, NB; Elliot, JM; Grounds, RM; Harper, NJ; Hunter, JM; Newman, PJ; Pearson, AJ; Pollard, BJ; Quinn, AC; Sutjarittam, M | 1 |
| Choonara, I; Playfor, SD; Thomas, DA | 2 |
| Audran, M; Bressolle, F; Farenc, C; Lefrant, JY | 1 |
| Greer, R; Harper, NJ; Russell, WC | 1 |
2 review(s) available for atracurium and Critical Illness
| Article | Year |
|---|---|
Use of cisatracurium in critical care: a review of the literature.
Topics: Atracurium; Critical Care; Critical Illness; Humans; Neuromuscular Nondepolarizing Agents | 2015 |
Atracurium and laudanosine pharmacokinetics in acute renal failure.
Topics: Acute Kidney Injury; Atracurium; Critical Illness; Humans; Isoquinolines; Metabolic Clearance Rate; Opium; Renal Dialysis | 1993 |
9 trial(s) available for atracurium and Critical Illness
| Article | Year |
|---|---|
Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
Topics: Acute Disease; Adult; Atracurium; Critical Illness; Cross-Over Studies; Double-Blind Method; Drugs, Generic; Female; Humans; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Monitoring; Respiration, Artificial; Respiratory Insufficiency | 2020 |
Muscular mass assessed by ultrasonography after administration of low-dose corticosteroids and muscle relaxants in critically ill hemiplegic patients.
Topics: Age Factors; APACHE; Atracurium; Critical Illness; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Hemiplegia; Humans; Intensive Care Units; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neuromuscular Nondepolarizing Agents; Serum Albumin; Time Factors; Treatment Outcome; Ultrasonography | 2002 |
Gastric emptying in mechanically ventilated critically ill patients: effect of neuromuscular blocking agent.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Atracurium; Conscious Sedation; Critical Illness; Female; Gastric Emptying; Humans; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies; Respiration, Artificial; Time Factors | 2003 |
Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Double-Blind Method; Electric Stimulation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Neuromuscular Junction; Prospective Studies; Respiration, Artificial; Stereoisomerism; Synaptic Transmission; Ulnar Nerve; Vecuronium Bromide | 1995 |
Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Care; Critical Illness; Drug Administration Schedule; Female; Humans; Isoquinolines; Male; Middle Aged; Nerve Block; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Respiration, Artificial; Stereoisomerism | 1996 |
A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Topics: APACHE; Atracurium; Critical Care; Critical Illness; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Linear Models; Male; Middle Aged; Neuromuscular Blocking Agents; Respiration, Artificial | 1997 |
Duration of action of atracurium when given by infusion to critically ill children.
Topics: Adolescent; Atracurium; Child; Child, Preschool; Critical Care; Critical Illness; Drug Tolerance; Female; Humans; Infant; Infusions, Intravenous; Male; Neuromuscular Nondepolarizing Agents | 2000 |
The effect of induced hypothermia on the duration of action of atracurium when given by infusion to critically ill children.
Topics: Adolescent; Atracurium; Child; Child, Preschool; Critical Care; Critical Illness; Female; Humans; Hypothermia, Induced; Infant; Infusions, Intravenous; Male; Neuromuscular Nondepolarizing Agents | 2000 |
Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Illness; Drug Administration Schedule; Humans; Infusions, Intravenous; Isoquinolines; Middle Aged; Models, Biological; Neuromuscular Nondepolarizing Agents; Respiration, Artificial; Respiratory Distress Syndrome | 2001 |
11 other study(ies) available for atracurium and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics studies of a loading dose of cisatracurium in critically ill patients with respiratory failure.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency | 2022 |
Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis.
Topics: Atracurium; COVID-19; Critical Illness; Humans; Neuromuscular Blocking Agents; Neuromuscular Monitoring; Retrospective Studies; SARS-CoV-2 | 2021 |
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
Topics: Aged; Atracurium; Critical Illness; Female; Humans; Infusions, Intravenous; Male; Monitoring, Physiologic; Neuromuscular Blocking Agents; Phlebitis | 2016 |
[Muscle relaxants in the ICU].
Topics: Androstanols; Atracurium; Critical Illness; Humans; Hypothermia, Induced; Intensive Care Units; Motor Endplate; Nervous System Diseases; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Pneumonia; Rocuronium; Sepsis; Succinylcholine; Thromboembolism; Vecuronium Bromide | 2009 |
The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis.
Topics: Adult; Aged; Atracurium; Critical Illness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Models, Biological; Neuromuscular Blocking Agents; Sepsis; Severity of Illness Index; Time Factors | 2012 |
The effect of neuromuscular blockers in patients with intra-abdominal hypertension.
Topics: Abdomen; Adult; Aged; Atracurium; Critical Illness; Female; Humans; Hypertension; Intensive Care Units; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies | 2007 |
Consensus guidelines for sustained neuromuscular blockade in critically ill children.
Topics: Androstanols; Atracurium; Child; Critical Care; Critical Illness; Humans; Monitoring, Intraoperative; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pancuronium; Rocuronium; Vecuronium Bromide | 2007 |
Doxacurium infusion in critically ill patients with atracurium tachyphylaxis.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Illness; Female; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Tachyphylaxis | 1995 |
Cost-effective treatment of atracurium resistance in critically ill patients.
Topics: Atracurium; Cost-Benefit Analysis; Critical Illness; Humans; Isoquinolines; Neuromuscular Nondepolarizing Agents; Pancuronium; Tachyphylaxis | 1995 |
Increased cis-atracurium requirements during prolonged administration to a child.
Topics: Atracurium; Critical Illness; Electric Stimulation; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Infant; Infusions, Intravenous; Isomerism; Monitoring, Physiologic; Multiple Organ Failure; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Respiration, Artificial | 1997 |
The effect of neuromuscular blockade on oxygen supply, consumption, and total chest compliance in patients with high oxygen requirements undergoing mechanical ventilation.
Topics: Adolescent; Adult; Atracurium; Conscious Sedation; Critical Illness; Female; Hemodynamics; Humans; Lung Compliance; Male; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Oxygen; Oxygen Consumption; Positive-Pressure Respiration | 2002 |